RTW Biotech Opportunities (LON:RTW – Get Free Report) shares were down 1.4% on Monday . The company traded as low as GBX 1.36 ($0.02) and last traded at GBX 1.37 ($0.02). Approximately 289,653 shares changed hands during trading, an increase of 96% from the average daily volume of 147,603 shares. The stock had previously closed at GBX 1.39 ($0.02).
RTW Biotech Opportunities Price Performance
The firm has a market capitalization of £4.60 million, a P/E ratio of 3.81 and a beta of 0.60. The stock’s 50 day moving average is GBX 1.42 and its two-hundred day moving average is GBX 1.50.
About RTW Biotech Opportunities
RTW Biotech Opportunities Ltd (LSE: RTW or RTWG) is an investment fund focused on identifying transformative assets with high growth potential across the biopharmaceutical and medical technology sectors. Driven by a long-term approach to support innovative businesses, RTW Biotech Opportunities invests in companies developing next-generation therapies and technologies that can significantly improve patients’ lives.
Further Reading
- Five stocks we like better than RTW Biotech Opportunities
- High Dividend REITs: Are They an Ideal Way to Diversify?
- How to Invest in Small Cap Stocks
- How Technical Indicators Can Help You Find Oversold Stocks
- These Are the Dividend Stocks Insiders Bought in January
- Industrial Products Stocks Investing
- How the ‘No Buy’ Trend of 2025 Is Boosting These 3 Stocks
Receive News & Ratings for RTW Biotech Opportunities Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RTW Biotech Opportunities and related companies with MarketBeat.com's FREE daily email newsletter.
